SOURCE: OR-Live, Inc.

June 11, 2008 13:15 ET

REMINDER: ORLive Presents: The Cryocath Spotlight Series: Insights and Implications for the Treatment of Atrial Fibrillation

Premiere Broadcast for European Physicians June 11th at 1800 Hours CEST

MONTREAL--(Marketwire - June 11, 2008) - CryoCath® Technologies Inc., the global leader in cryotherapy products to treat cardiac arrhythmias, is pleased to report on its participation in Heart Rhythm 2008, the most prominent and comprehensive educational event on heart rhythm disorders. The event was held from May 14 to 17 at the Moscone Convention Center in San Francisco. This year, the meeting attracted a record-breaking 13,600 attendees and provided 250 educational opportunities in multiple formats. The world's leading electrophysiologists presented a broad range of heart rhythm topics.

CryoCath marked its presence at this prestigious gathering with 12 poster presentations and 10 well-attended oral presentations. For the most part, these presentations focused on the Arctic Front® cryo-balloon system for pulmonary-vein isolation in the treatment of paroxysmal atrial fibrillation. Other presentations dealt with CryoCath's family of focal catheters for the treatment of a range of arrhythmias.

CryoCath's presence at Heart Rhythm 2008 provided the company with an excellent opportunity to further familiarize physicians with the growing body of evidence in favour of the cryo-balloon approach in the treatment of AF. This included the consistent, positive results from multiple centres reported at the most recent Annual Meeting of the German Cardiac Society in Mannheim in March 2008.

Intended for European physicians, this world-wide-web 'Premier Showing' of the San Francisco SPOTLIGHT series program recaps a presentation from Dr. Marcus Koller, Cardiovascular Center, Bad Neustadt, Germany and is chaired by Dr. Wyn Davies, St. Mary's Hospital, London. These notable authorities will discuss the potential safety of cryo technologies, the Arctic Front minimally invasive cryo-balloon catheter, the simplicity of the procedure and favorable patient outcomes.

About Arctic Front

Arctic Front is a minimally invasive cryo-balloon catheter designed specifically to treat paroxysmal Atrial Fibrillation. This bi-directional, double balloon catheter enables physicians to rapidly isolate all four pulmonary veins for the treatment of AFib. Over 2,600 patients have been treated in over 45 centres across Europe. Arctic Front is CE marked in Europe and in the USA is an Investigational Device -- Limited by Federal Law to Investigational Use.

About CryoCath

CryoCath -- -- is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.

To view a program preview and learn more visit: OR-Live


Contact Information